Fate Therapeutics Inc. (FATE) at a glance

Fate Therapeutics Inc. (FATE) is a micro-cap Healthcare company. It trades at $2.42, with a 0% profit margin and revenue decline of 20.3%. It does not pay a dividend. Vestovix scores it 34/100 overall. Its strongest dimension is Momentum (61/100) and its weakest is Safety (1/100). It carries above-market volatility, so expect larger swings.

Price

$2.43

Market cap

$240.1M

P/E ratio

n/a

Dividend yield

None

Beta

2.52

52-week range

$0.93 to $3.23